The supplied evidence records contain sufficient quantitative data to graph the peritoneal dialysis (PD) peritonitis eryptosis study directly: PD-peritonitis patients (n=22) showed 7.7% eryptotic RBCs (IQR 4.3β14.2) vs 0.8% (IQR 0.7β1.3) in healthy controls (n=17), p<0.001, measured by Annexin V-FITC flow cytometry . Correlations of eryptosis with peritoneal biomarkers are also reported (pWBC rho=0.77; pNGAL rho=0.64; IL-6 rho=0.61; IL-1Ξ² rho=0.64).
A second decisive figure plots the reported Spearman correlations between systemic eryptosis and peritoneal dialysis effluent (PDE) biomarkers, showing local peritoneal inflammation tracks with RBC death .
Analysis plan notes: Graph only values reported above; the record does not provide subject-level data, so box plots represent median + IQR whiskers only (approximation, not full distributions). For a PD cohort graphing pipeline: load the extracted table (pandas), render Annexin V percentages and Spearman Ο with Plotly, annotate p-values, and clearly flag that n=22/17 is small, single-center, and cross-sectional . Related context: the PD stable-cohort review (n=46) reports higher eryptosis in PD vs controls and lower eryptosis with residual diuresis, but only qualitatively β insufficient data to plot without fabricating values.
Know what changed, what holds up, and what remains uncertain. Every Friday. No ads.